{"nct_id":"NCT04026412","title":"A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2019-10-08","start_date_type":"ACTUAL","primary_completion_date":"2024-03-22","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-26","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}